Study guide
7.4 Calibration, Verification, Validation & Maintenance of Equipment
BCSCP Board Certified Sterile Compounding Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, USP Standards & CSP Categories
1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions
2 Chapter 2: Facilities, Engineering Controls & Cleaning
2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures
3 Chapter 3: Environmental Monitoring & Facility Certification
3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols
4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique
4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity
5 Chapter 5: Beyond-Use Dating, Storage & Container Rules
5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules
6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding
6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)
7 Chapter 7: Materials, Equipment & Compounding Workflow
7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs
8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility
8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics
9 Chapter 9: Therapeutics, Administration & Patient Monitoring
9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations
10 Chapter 10: Quality Management, Records & Personnel Competency
10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence
11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain
11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA
12 Chapter 12: Safety Management, Investigations, Recalls & Waste
12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management
7.4 Calibration, Verification, Validation & Maintenance of Equipment
Key Takeaways Explain This Topic AI
Calibration adjusts an instrument against a traceable standard; verification checks that it still reads within tolerance; validation proves that a process (sterilization, depyrogenation, cleaning) consistently achieves its result; maintenance keeps equipment within its performance limits.
USP <797> requires PECs and classified rooms to be certified initially and at least every 6 months, and a CVE, BSC or CACI used for presterilization steps is also certified at least every 6 months.
Temperature, humidity and pressure monitoring devices are calibrated or verified as the manufacturer recommends, or every 12 months if no interval is given.
Steam and dry heat sterilization are verified with biological indicators with every run or load, and depyrogenation cycles with endotoxin challenge vials initially and at least annually.
When equipment is found out of tolerance, it is taken out of service and repaired or recalibrated, and the CSPs made since the last acceptable check are assessed. All of this is documented, as USP <797> Section 20 requires.
Last updated: September 2026
7.4 Calibration, Verification, Validation & Maintenance of Equipment
Every measurement a compounding pharmacist relies on comes from equipment: particle counts, pressure readings, delivered volumes, weights, incubation temperatures, sterilizer cycles. If that equipment is off, the data are wrong, and a CSP can look acceptable when it is not. The BCSCP outline (task 1A8) expects you to design and supervise the program that keeps every instrument trustworthy.
Four terms that exams mix up
Term Meaning Example
Calibration Comparing an instrument with a traceable standard and adjusting it, documenting the before and after values A service technician calibrates a balance with certified weights
Verification Checking that an instrument or process still performs within tolerance, without adjusting it Daily balance check with a test weight; daily ACD accuracy check
Validation Documented evidence that a process consistently produces the intended result Proving an autoclave cycle sterilizes a defined load; proving a depyrogenation cycle gives a 3-log endotoxin reduction
Maintenance Preventive and corrective work that keeps equipment within its limits Replacing ACD pump tubing on schedule; replacing a HEPA filter
For sterilizers and similar equipment, validation is often organized as installation qualification (IQ) , operational qualification (OQ) and performance qualification (PQ) . IQ shows the equipment is installed correctly, OQ that it works across its operating ranges, and PQ that it performs the real process on real loads.
Master table of checks and intervals
Equipment or process Requirement Source
PECs and classified rooms Certified initially, then at least every 6 months: airflow, HEPA leak test, total particle count under dynamic conditions, smoke pattern tests. Also after redesign, construction, PEC replacement or relocation, or changes affecting airflow. The designated person reviews every report USP <797> 5
CVE, BSC or CACI used for presterilization weighing Certified at least every 6 months USP <797> 4.2.6
Laminar airflow systems and robotic enclosures Dynamic smoke test initially and at least every 6 months USP <797> 4.2.3
Pressure-differential monitors Monitor continuously; results reviewed and documented daily on compounding days; calibrated or verified per manufacturer or every 12 months USP <797> 4.2.5; FAQ
Temperature and humidity devices (rooms, storage, refrigerators) Calibrated or verified per manufacturer, or every 12 months if unspecified USP <797> 9.3.4, 19.1
Automated compounding devices Accuracy assessed before first use and each day used; daily record; corrective action if out of specification USP <797> 9.1
Balances Checked per SOP (commonly daily) with test weights; periodic calibration; must meet USP <41> repeatability and accuracy USP <41>, <1251>
Impaction air samplers Serviced and calibrated as the manufacturer recommends USP <797> 6.1
Incubators Temperature monitored and documented throughout incubation; located outside the sterile compounding area USP <797> 6.2.2, 6.3.2
Steam sterilizer Biological indicators (for example Geobacillus stearothermophilus ) with each run or load; calibrated recorder for each cycle; steam from water meeting the manufacturer's specification; run and load numbers in the compounding record USP <797> 10.3
Dry heat sterilizer Biological indicators ( Bacillus atrophaeus ) with each run or load; calibrated recorder; even heat distribution USP <797> 10.4
Depyrogenation oven Effectiveness shown initially and at least annually with endotoxin challenge vials (at least a 3-log reduction); re-established after changes to load, time or temperature USP <797> 10.1
- Sterilizing filters Integrity test (such as bubble point) after each use USP <797> 10.2
- Growth media Supplier COA for commercial media; growth promotion testing of each in-house batch USP <797> 2.3
- Out-of-tolerance findings
When a check fails, for example a balance reading 0.3% high on its daily test weight, the response follows a set pattern:
Take the equipment out of service and label it.
Assess the impact. Identify the CSPs made with it since the last acceptable check and judge whether their quality could have been affected. Quarantine or recall them under the SOPs if necessary.
Repair or recalibrate , then verify before returning the equipment to service.
Document the finding, the impact assessment and the corrective action, and look for trends.
This is why daily verification pays off. It limits how far back you have to look when something goes wrong.
Maintenance and servicing
Equipment used in classified areas stays there except for calibration, servicing or cleaning. When it comes back, it is cleaned and wiped with sterile 70% IPA or a suitable disinfectant.
Servicing facilities or equipment triggers microbiological air and surface sampling . That includes changing HEPA filters in the ceiling or the PEC; routine prefilter changes usually do not trigger it.
Preventive maintenance schedules, such as ACD tubing changes, sterilizer gaskets and HEPA filter replacement plans, come from the manufacturer's instructions and belong in the SOPs.
Records
USP <797> Section 20 requires records of equipment calibration, verification and maintenance, along with certification reports and any corrective actions for failures. Inspectors often look at these first, because gaps show quickly.